· Venture Capital Tracker · investment-strategies  · 2 min read

Seed to Series A, B, C, D: What Every Startup Funding Round Actually Means

The complete 2026 guide to startup funding rounds — typical round sizes, valuations, metrics expected, and what each round is really for.

Startup funding rounds follow a well-defined progression — each round has a purpose, expected metrics, typical size, and set of investors.

Pre-seed (Founders / Angels / Accelerators)

  • Purpose: Build MVP, validate initial insight.
  • Round size: $250K–$3M.
  • Valuation (post-money): $5M–$15M.
  • Instruments: SAFEs, convertible notes.
  • Lead investors: Pre-seed VCs, angels, accelerators (YC, Techstars), scouts.
  • Metrics expected: Compelling founders, clean problem insight, early product demo.

Seed

  • Purpose: Prove early product-market fit; hire a small team.
  • Round size: $2M–$8M (increasingly $5M–$15M for AI-native).
  • Valuation: $10M–$40M.
  • Instruments: SAFEs stack or priced seed.
  • Lead investors: Seed-focused funds (First Round, Initialized, Uncork, Primary, Hustle Fund).
  • Metrics expected: Early usage or revenue, initial customer love, product velocity.

Series A

  • Purpose: Scale a proven wedge; build repeatable GTM.
  • Round size: $10M–$25M (higher for AI, defense, hardware).
  • Valuation: $40M–$150M.
  • Instruments: Preferred equity with full VC terms.
  • Lead investors: Brand Series A funds (Benchmark, Sequoia, a16z, Accel, Index, Atomico).
  • Metrics expected: $1M–$5M ARR (SaaS), clear retention, CAC payback within 12–24 months.

Series B

  • Purpose: Scale the scaled wedge; expand team; new markets.
  • Round size: $20M–$60M.
  • Valuation: $150M–$500M.
  • Lead investors: Growth funds, Series B specialists (Insight, Bessemer, ICONIQ).
  • Metrics expected: $5M–$20M ARR, net-revenue retention > 110%, clear unit economics.

Series C and beyond

  • Purpose: Category leadership, international expansion, acquisition funding.
  • Round size: $50M+ (often $100M–$500M).
  • Valuation: $500M–$10B+.
  • Lead investors: Crossover investors (Tiger, Coatue, Dragoneer, DST), late-stage VCs, PE growth arms.
  • Metrics expected: $20M+ ARR, profitability trajectory visible, IPO-readiness forming.

Mega rounds (D, E, F, G)

  • Now routine for AI category leaders.
  • OpenAI’s $122B and Waymo’s $16B in 2026 pushed round sizes that didn’t exist 5 years ago.
  • Lead investors: Sovereign wealth, hyperscalers, crossover funds, late-stage VCs.

The Series A crunch

In most cohorts, 60–70% of seed-funded U.S. startups never raise a Series A. Typical causes:

  1. Not enough revenue/retention velocity.
  2. Market is too small or slow.
  3. Team fragmentation.
  4. Cash runway mismanaged.

Practical takeaway

  1. Founders: Don’t optimize for round title — optimize for runway, milestones, and investor fit.
  2. Investors: Stage discipline (sticking to your thesis) protects returns better than chasing hot stages.
  3. Operators: Understand Series A metrics 18 months before you need them.

Further reading

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.